• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

鲑鱼降钙素鼻喷雾剂治疗骨Paget病：5例患者的初步结果

Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.

作者信息

Reginster J Y, Albert A, Franchimont P

出版信息

Calcif Tissue Int. 1985 Dec;37(6):577-80. doi: 10.1007/BF02554908.

DOI:10.1007/BF02554908
PMID:3937575
Abstract

The effectiveness of Synthetic Salmon Calcitonin (SSCT) administered as a nasal spray was assessed via clinical, biological, and radiological variables in 5 Pagetic patients during a 6 months course therapy, the results show that intranasal administration does not decrease the activity of SSCT in Paget's disease of bone.

摘要

通过临床、生物学和放射学变量，对5名佩吉特病患者在6个月疗程中使用鼻喷雾剂形式的合成鲑鱼降钙素（SSCT）的有效性进行了评估，结果显示经鼻给药不会降低SSCT在骨佩吉特病中的活性。

相似文献

1
Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.鲑鱼降钙素鼻喷雾剂治疗骨Paget病：5例患者的初步结果
Calcif Tissue Int. 1985 Dec;37(6):577-80. doi: 10.1007/BF02554908.
2
One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.使用合成鲑鱼降钙素鼻喷雾剂对骨佩吉特病进行为期一年的治疗。
J Bone Miner Res. 1988 Jun;3(3):249-52. doi: 10.1002/jbmr.5650030302.
3
[Calcitonin nasal spray for Paget's disease of the bone].
Harefuah. 1995 Mar 15;128(6):358-62, 399.
4
Treatment of Paget's disease of bone with salmon calcitonin nasal spray.鲑鱼降钙素鼻喷雾剂治疗骨Paget病
J Am Geriatr Soc. 1988 Nov;36(11):1010-4.
5
The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases.鼻内人降钙素对骨Paget病骨转换的影响——对其他代谢性骨病治疗的启示
Br J Rheumatol. 1992 Jan;31(1):35-9. doi: 10.1093/rheumatology/31.1.35.
6
Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
Am J Med. 1990 Aug;89(2):181-4. doi: 10.1016/0002-9343(90)90297-q.
7
Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
Metabolism. 1974 Nov;23(11):1037-46. doi: 10.1016/0026-0495(74)90070-5.
8
Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
JAMA. 1972 Sep 4;221(10):1127-9. doi: 10.1001/jama.221.10.1127.
9
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.特异性抗鲑鱼降钙素抗体对鼻用鲑鱼降钙素治疗佩吉特骨病生物学有效性的影响。
Scand J Rheumatol. 1990;19(1):83-6. doi: 10.3109/03009749009092626.
10
Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.佩吉特骨病：对鲑降钙素耐药患者对人降钙素的反应。
Lancet. 1974 Dec 14;2(7894):1412-5. doi: 10.1016/s0140-6736(74)90072-5.

引用本文的文献

1
Increase of pain threshold by calcitonin during electrical stimulation of the dental pulp. Investigations in healthy volunteers with regard to plasma concentration.降钙素在牙髓电刺激期间对疼痛阈值的提高作用。关于血浆浓度的健康志愿者研究。
Schmerz. 1989 Sep;3(3):118-32. doi: 10.1007/BF02527389.
2
The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.有和没有渗透促进剂情况下，健康志愿者鼻内注射鲑鱼降钙素的生物利用度。
Pharm Res. 1994 May;11(5):747-50. doi: 10.1023/a:1018992716621.
3
Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.

本文引用的文献

1
A new "kinetic" method for enzyme analysis suitable for automation.
Clin Chem. 1969 Jun;15(6):452-9.
骨质疏松症和佩吉特病的管理。药物治疗的风险与益处评估。
Drug Saf. 1994 Sep;11(3):179-95. doi: 10.2165/00002018-199411030-00004.
4
Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.鲑鱼降钙素经鼻内和肌肉注射给药对佩吉特病的急性效应比较。
Calcif Tissue Int. 1987 Dec;41(6):313-5. doi: 10.1007/BF02556668.
5
The effect of rectal and nasal administration of salmon calcitonin in normal subjects.
Calcif Tissue Int. 1987 Nov;41(5):252-8. doi: 10.1007/BF02555225.
6
Intranasal absorption of salmon calcitonin.
Calcif Tissue Int. 1987 Nov;41(5):249-51. doi: 10.1007/BF02555224.
7
The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calcium.
Calcif Tissue Int. 1990 Jan;46(1):5-8. doi: 10.1007/BF02555817.
8
Effect of different doses of nasal salmon calcitonin on bone mass.不同剂量鼻用鲑降钙素对骨量的影响。
Calcif Tissue Int. 1991 May;48(5):302-7. doi: 10.1007/BF02556148.
9
Future horizons for calcitonin: a U.S. perspective.降钙素的未来展望：美国视角
Calcif Tissue Int. 1991;49 Suppl 2:S2-6. doi: 10.1007/BF02561368.
10
Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging.鼻内用鲑鱼降钙素。其药理特性及在与衰老相关的代谢性骨病中的潜在应用综述。
Drugs Aging. 1991 Sep-Oct;1(5):405-23. doi: 10.2165/00002512-199101050-00007.